Targeted Low-Dose Hyaluronidase Successfully Resolves Hyaluronic Acid Facial Vascular Occlusion
A retrospective clinical case series demonstrates that targeted low-dose hyaluronidase can halt ischemic progression and resolve facial vascular occlusion caused ...

